Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …

Erythropoiesis, the development of erythrocytes from hematopoietic stem cells, occurs
through four phases: erythroid progenitor development, early erythropoiesis, terminal …

Background Flow cytometry (FCM) is a co‐criterion in myelodysplastic syndromes (MDS)
diagnostics according to the WHO classification. The presented study compared diagnostic …

Background Although flow cytometric detection of myelodysplastic syndrome (MDS) with the
Ogata score has a high specificity, its sensitivity for low-grade MDS is low. Additional …

During the process of hematopoiesis, hematopoietic stem cells (HSCs) undergo hierarchical
differentiation and maturation to develop into mature effector cells through a tightly regulated …

Background Flow cytometry immunophenotyping (FCIP) can improve diagnosis of
myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms …

Chronic myeloid neoplasms including myelodysplastic neoplasms (MDS) and
myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell (HSC) disorders …

Background: Patients with myelodysplastic syndromes (MDS) with progenitors expressing
CD41 (CD41+ MDS) showed a poor prognosis in a previous study but their detailed …

Abstract Introduction The myelodysplastic syndromes (MDSs) are heterogeneous myeloid
malignancies, conventionally diagnosed by cytomorphology and cytogenetics, with an …

This fourth edition presents an updated and expanded text and illustrations to reflect
continued morphologic, immunophenotypic, and especially molecular advances in the field …